MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock [Yahoo! Finance]
Merck & Co., Inc. (NYSE: MRK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $115.00 price target on the stock.
Merck (NYSE:MRK) Secures Global Rights To Cyprumed's Oral Peptide Delivery Technology [Yahoo! Finance]
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth? [Yahoo! Finance]